AI in Drug Development is Not a Data Problem — It’s An Evidence Problem
Drug development isn't limited by the amount of data we collect, but by our ability to preserve the context, meaning and relationships that transform data into evidence.
Narasimha Kumar
Narasimha Kumar, Global Head of Technology and Data Services, BC Platforms, brings 25+ years of experience in technology consulting, AI product management, and compliance across life sciences and healthcare. Previously Chief Product and Commercial Officer at Datafoundry AI and senior leader at PAREXEL International, Narashimha specialises in AI-driven platforms and cloud transformation.